A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye
Clinical trial NCT05109702 · COMPLETED
Trial details
- NCT number
- NCT05109702
- Sponsor
- HanAll BioPharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2022-05-06
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.